{"id":"https://openalex.org/W4407678366","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.439","title":"Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial.","display_name":"Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial.","publication_year":2025,"publication_date":"2025-02-10","ids":{"openalex":"https://openalex.org/W4407678366","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.439"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2025.43.5_suppl.439","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.439","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.439","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059063118","display_name":"Robert John Motzer","orcid":"https://orcid.org/0000-0001-6925-2327","observed_orcids":["https://orcid.org/0000-0001-6925-2327"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Motzer","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049672639","display_name":"Bernard J. Escudier","orcid":"https://orcid.org/0000-0002-4626-0479","observed_orcids":["https://orcid.org/0000-0002-4626-0479"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bernard Escudier","raw_affiliation_strings":["Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074832020","display_name":"Mauricio Burotto","orcid":"https://orcid.org/0000-0002-7150-4033","observed_orcids":["https://orcid.org/0000-0002-7150-4033"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mauricio Burotto","raw_affiliation_strings":["Bradford Hill Clinical Research Center, Santiago, Chile"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bradford Hill Clinical Research Center, Santiago, Chile","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089861374","display_name":"Thomas B. Powles","orcid":"https://orcid.org/0000-0001-7760-4724","observed_orcids":["https://orcid.org/0000-0001-7760-4724"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Powles","raw_affiliation_strings":["Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free National Health Service Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free National Health Service Trust, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801138448","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039083730","display_name":"Andrea Borghese Apolo","orcid":"https://orcid.org/0000-0001-9409-1836","observed_orcids":["https://orcid.org/0000-0001-9409-1836"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea B Apolo","raw_affiliation_strings":["Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003919218","display_name":"Maria Teresa Bourlon","orcid":"https://orcid.org/0000-0002-3116-912X","observed_orcids":["https://orcid.org/0000-0002-3116-912X"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Maria T. Bourlon","raw_affiliation_strings":["Urologic Oncology Clinic, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, DF, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urologic Oncology Clinic, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, DF, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017490262","display_name":"Amishi Yogesh Shah","orcid":"https://orcid.org/0000-0002-9007-0621","observed_orcids":["https://orcid.org/0000-0002-9007-0621"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amishi Yogesh Shah","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018910230","display_name":"Camillo Porta","orcid":"https://orcid.org/0000-0003-2412-1563","observed_orcids":["https://orcid.org/0000-0003-2412-1563"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Camillo Porta","raw_affiliation_strings":["University of Bari Aldo Moro, Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro, Bari, Italy","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079620361","display_name":"Cristina Su\u00e1rez","orcid":"https://orcid.org/0000-0002-0502-5528","observed_orcids":["https://orcid.org/0000-0002-0502-5528"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Su\u00e1rez","raw_affiliation_strings":["Vall d\u2019Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u2019Hebron, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u2019Hebron, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102881127","display_name":"Carlos H. Barrios","orcid":"https://orcid.org/0000-0001-6021-667X","observed_orcids":["https://orcid.org/0000-0001-6021-667X"]},"institutions":[{"id":"https://openalex.org/I4405253759","display_name":"Latin American Cooperative Oncology Group (LACOG)","ror":"https://ror.org/0123wax79","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4405253759"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Carlos H. Barrios","raw_affiliation_strings":["Latin American Cooperative Oncology Group (LACOG) - Porto Alegre, Brazil Oncoclinicas Group, Porto Alegre, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Latin American Cooperative Oncology Group (LACOG) - Porto Alegre, Brazil Oncoclinicas Group, Porto Alegre, Brazil","institution_ids":["https://openalex.org/I4405253759"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081758087","display_name":"Martin Eduardo Richardet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Martin Eduardo Richardet","raw_affiliation_strings":["Fundaci\u00f3n Richardet Longo, Instituto Oncol\u00f3gico de C\u00f3rdoba, C\u00f3rdoba, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3n Richardet Longo, Instituto Oncol\u00f3gico de C\u00f3rdoba, C\u00f3rdoba, Argentina","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041526616","display_name":"Howard Gurney","orcid":"https://orcid.org/0000-0003-0217-5261","observed_orcids":["https://orcid.org/0000-0003-0217-5261"]},"institutions":[{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Howard Gurney","raw_affiliation_strings":["Westmead Hospital and Macquarie University, Westmead and Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Westmead Hospital and Macquarie University, Westmead and Sydney, NSW, Australia","institution_ids":["https://openalex.org/I2803024705","https://openalex.org/I99043593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044287083","display_name":"Elizabeth Riley Kessler","orcid":"https://orcid.org/0000-0001-7285-867X","observed_orcids":["https://orcid.org/0000-0001-7285-867X"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth R. Kessler","raw_affiliation_strings":["University of Colorado School of Medicine, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado School of Medicine, Aurora, CO","institution_ids":["https://openalex.org/I51713134","https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007596741","display_name":"Yoshihiko Tomita","orcid":"https://orcid.org/0000-0002-7465-9591","observed_orcids":["https://orcid.org/0000-0002-7465-9591"]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiko Tomita","raw_affiliation_strings":["Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080116321","display_name":"Jens Bedke","orcid":"https://orcid.org/0000-0003-2778-3108","observed_orcids":["https://orcid.org/0000-0003-2778-3108"]},"institutions":[{"id":"https://openalex.org/I4210161485","display_name":"Klinikum Stuttgart","ror":"https://ror.org/059jfth35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210161485"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Bedke","raw_affiliation_strings":["Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210161485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085625313","display_name":"Fatima A. Rangwala","orcid":"https://orcid.org/0000-0003-4228-7604","observed_orcids":["https://orcid.org/0000-0003-4228-7604"]},"institutions":[{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fatima A. Rangwala","raw_affiliation_strings":["Exelixis, Inc., Alameda, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exelixis, Inc., Alameda, CA","institution_ids":["https://openalex.org/I152988861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077250846","display_name":"Margarita Askelson","orcid":"https://orcid.org/0000-0001-9133-7693","observed_orcids":["https://orcid.org/0000-0001-9133-7693"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margarita Askelson","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112574813","display_name":"Julie Panzica-Kelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Panzica","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033242239","display_name":"Viktor Fedorov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viktor Fedorov","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052504518","display_name":"Toni K. Choueiri","orcid":"https://orcid.org/0000-0002-9201-3217","observed_orcids":["https://orcid.org/0000-0002-9201-3217"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Toni K. Choueiri","raw_affiliation_strings":["Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]}],"institutions":[],"countries_distinct_count":11,"institutions_distinct_count":28,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"5_suppl","first_page":"439","last_page":"439"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9279999732971191},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/advanced-renal-cell-carcinoma","display_name":"advanced renal cell carcinoma","score":0.9369999766349792},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8349999785423279},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8700000047683716},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8450000286102295},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.996999979019165},{"id":"https://openalex.org/keywords/imdc-risk-stratification","display_name":"IMDC risk stratification","score":0.8960000276565552},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7480000257492065},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.628000020980835},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.40700000524520874},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.5009999871253967},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9540379643440247},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.9476673603057861},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.921384334564209},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7991906404495239},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.753205418586731},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5219647288322449},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4729230999946594},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.4287441670894623},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.40401044487953186},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36431407928466797},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20496299862861633},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.16619977355003357}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2025.43.5_suppl.439","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.439","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.439","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391303247","https://openalex.org/W4324136722","https://openalex.org/W3166432245","https://openalex.org/W3201888489","https://openalex.org/W3168247338","https://openalex.org/W4394981274","https://openalex.org/W4414480998","https://openalex.org/W4212900770","https://openalex.org/W3088188638","https://openalex.org/W7162557446"],"abstract_inverted_index":{"439":[0],"Background:":[1],"N+C":[2,161,194,226,247,289,319,340],"showed":[3],"significant":[4],"benefits":[5],"vs":[6,162,179,189,195,210,220,227,230,236,248,252,285,290],"S":[7,94,163,196,228,249,321],"in":[8,58,262,282,322],"progression-free":[9],"survival":[10,13],"(PFS),":[11],"overall":[12],"(OS),":[14],"and":[15,62,71,138],"objective":[16,509],"response":[17,233,240],"rate":[18],"(ORR)":[19],"for":[20,45,346],"patients":[21],"(pts)":[22],"with":[23,48,75,225,246,288,318,508],"previously":[24,347],"untreated":[25,348],"aRCC":[26,76],"from":[27,326],"the":[28,46,263,302],"phase":[29],"3":[30],"CheckMate":[31,327],"9ER":[32],"trial":[33,47,351],"(":[34],"N":[35,82,112],"Engl":[36],"J":[37],"Med":[38],"2021;":[39],"384:829\u201341).":[40],"We":[41],"report":[42],"final":[43,324],"results":[44,336],"a":[49,342,485,504],"long-term":[50],"follow-up":[51,142,325],"(min,":[52],">5":[53],"y),":[54],"including":[55],"updated":[56],"efficacy":[57,314],"intent-to-treat":[59],"(ITT)":[60],"pts":[61,150,268,507],"by":[63,122,136,256],"International":[64],"Metastatic":[65],"RCC":[66],"Database":[67],"Consortium":[68],"(IMDC)":[69],"risk,":[70],"safety.":[72,139],"Methods:":[73],"Pts":[74],"were":[77,187,218,250,330],"randomized":[78],"to":[79,296,338],"receive":[80],"first-line":[81],"240":[83],"mg":[84,91,96],"every":[85],"2":[86],"wk":[87,99],"+":[88],"C":[89],"40":[90],"QD":[92,97],"or":[93,107],"50":[95],"(4":[98],"of":[100,239,344],"each":[101,272],"6-wk":[102],"cycle)":[103],"until":[104],"disease":[105],"progression":[106],"unacceptable":[108],"toxicity":[109,299],"(2":[110],"y":[111],"max.).":[113],"The":[114,335],"primary":[115],"endpoint":[116],"was":[117,143,176,207,223,316],"PFS":[118,159,174,185,379,409],"per":[119,133],"RECIST":[120,134],"v1.1":[121,135],"blinded":[123],"independent":[124],"central":[125],"review":[126],"(BICR).":[127],"Secondary":[128],"endpoints":[129],"included":[130],"OS,":[131],"ORR":[132,222,457],"BICR,":[137],"Results:":[140],"Median":[141,171,202],"67.6":[144],"(range,":[145],"60.2\u201380.2)":[146],"mo.":[147],"In":[148,265],"ITT":[149],"(N+C,":[151],"n":[152,156,356,360,364,368,372,376],"=":[153,157,270,357,361,365,369,373,377],"323;":[154],"S,":[155],"328),":[158],"favored":[160,193],"(hazard":[164],"ratio":[165],"[HR],":[166],"0.58":[167],"[95%":[168,199],"CI,":[169,200],"0.49\u20130.70]).":[170],"(95%":[172,203,381,393,420,432,458],"CI)":[173,204,382,421],"(mPFS)":[175],"16.4":[177],"(12.5\u201319.3)":[178],"8.3":[180],"(7.0\u20139.7)":[181],"mo,":[182,213],"respectively;":[183,214],"60-mo":[184,215,408,447,481],"rates":[186,217,242],"13.6%":[188],"3.6%.":[190],"OS":[191,205,216,418,448],"also":[192],"(HR,":[197],"0.79":[198],"0.65\u20130.96]).":[201],"(mOS)":[206],"46.5":[208],"(40.6\u201353.8)":[209],"35.5":[211],"(29.2\u201342.8)":[212],"40.9%":[219],"35.4%.":[221],"greater":[224],"(55.7%":[229],"27.4%;":[231],"complete":[232],"[CR],":[234],"13.9%":[235],"4.6%).":[237],"Duration":[238],"(DOR)":[241],"at":[243],"60":[244],"mo":[245,395,434],"22.0%":[251],"10.0%,":[253],"respectively.":[254],"Efficacy":[255],"IMDC":[257,493,496,502],"risk":[258],"groups":[259],"is":[260],"reported":[261],"Table.":[264],"all":[266],"treated":[267],"(n":[269],"320":[271],"arm),":[273],"any-grade":[274],"(grade":[275],"\u2265":[276],"3)":[277],"treatment-related":[278],"adverse":[279],"events":[280],"occurred":[281,300],"97.5%":[283],"(67.8%)":[284],"93.1%":[286],"(55.3%)":[287],"S.":[291],"No":[292],"new":[293,332],"deaths":[294],"due":[295],"study":[297],"drug":[298],"since":[301],"last":[303],"database":[304],"lock.":[305],"Additional":[306],"subgroup":[307],"analyses":[308],"will":[309],"be":[310],"presented.":[311],"Conclusions:":[312],"Long-term":[313],"benefit":[315],"observed":[317],"over":[320],"this":[323],"9ER.":[328],"There":[329],"no":[331],"safety":[333],"signals.":[334],"continue":[337],"support":[339],"as":[341],"standard":[343],"care":[345],"aRCC.":[349],"Clinical":[350],"information:":[352],"NCT03141177":[353],".":[354],"FAVN+C;":[355],"74":[358],"FAVS;":[359],"72":[362],"INTN+C;":[363],"188":[366,370],"INTS;":[367],"PoorN+C;":[371],"61":[374],"PoorS;":[375],"68":[378],"HR":[380,419],"0.67":[383],"(0.46\u20130.97)":[384],"-":[385,388,391,424,427,430],"0.63":[386],"(0.50\u20130.80)":[387],"0.36":[389],"(0.23\u20130.56)":[390],"mPFS":[392],"CI),":[394,433,459],"21.4":[396],"(12.8\u201324.6)":[397],"12.8":[398],"(9.4\u201316.6)":[399],"16.6":[400],"(11.3\u201321.7)":[401],"8.5":[402],"(6.9\u201310.4)":[403],"9.9":[404],"(5.9\u201317.7)":[405],"4.2":[406],"(2.9\u20135.7)":[407],"rate,":[410,449,483],"%":[411,450,460,474,484],"15.1":[412],"3.9":[413],"12.7":[414],"4.7":[415],"15.7":[416],"0":[417,491],"1.08":[422],"(0.70\u20131.66)":[423],"0.86":[425],"(0.67\u20131.11)":[426],"0.49":[428],"(0.33\u20130.74)":[429],"mOS":[431],"53.7":[435],"(40.8\u201370.7)":[436],"58.9":[437],"(46.1\u2013NE)":[438],"47.4":[439],"(38.2\u201355.8)":[440],"36.2":[441],"(25.7\u201346.3)":[442],"34.8":[443],"(21.4\u201353.4)":[444],"10.5":[445],"(6.8\u201320.7)":[446],"46.3":[451],"49.4":[452],"41.2":[453],"38.2":[454],"33.1":[455],"12.9":[456],"66.2":[461],"(54.3\u201376.8)":[462],"43.1":[463],"(31.4\u201355.3)":[464],"55.9":[465],"(48.4\u201363.1)":[466],"27.7":[467],"(21.4\u201334.6)":[468],"42.6":[469],"(30.0\u201355.9)":[470],"10.3":[471],"(4.2\u201320.1)":[472],"CR,":[473],"16.2":[475],"6.9":[476],"15.4":[477],"4.8":[478],"6.6":[479],"1.5":[480],"DOR":[482],"22.0":[486],"NE":[487],"19.0":[488],"13.0":[489],"37.0":[490],"FAV,":[492],"favorable;":[494],"INT,":[495],"intermediate;":[497],"NE,":[498],"not":[499],"estimable;":[500],"poor,":[501],"poor.":[503],"Based":[505],"on":[506],"response.":[510]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2025-02-18T00:00:00"}